Tulathromycin Patent Expiration
About Veterinary Tulathromycin
Tulathromycin is used in drugs marketed by 10 different companies: Intervet Inc, Virbac Ah Inc, Norbrook Laboratories Ltd, Hikma Pharmaceuticals Usa Inc, Cronus Pharma Specialities India Private Ltd, Ceva Sante Animale, Elanco Us Inc, Parnell Technologies Pty Ltd, Bimeda Animal Health Limited, Zoetis Inc.
Other drugs containing Tulathromycin are: Increxxa 25 , Tulaject 100 , Increxxa , Tulaven 25
Veterinary Tulathromycin Patents
Given below is the list of patents protecting Tulathromycin, along with the drug name that holds that patent and the company owning that drug.
| Drug Used In | Drug Patent Number | Drug Patent Expiry | Drug Owner |
|---|---|---|---|
 | |||
| Draxxin 25 Injectable Solution | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6777393 | 29 May, 2018 | ZOETIS INC. |
| Draxxin 25 Injectable Solution | US6936592 | 29 May, 2018 | ZOETIS INC. |
| Draxxin | US6583274 | 02 May, 2020 | ZOETIS INC. |
| Draxxin | US6329345 | 18 Nov, 2019 | ZOETIS INC. |
| Draxxin | US6420536 | 24 May, 2019 | ZOETIS INC. |
| Draxxin | US6777393 | 29 May, 2018 | ZOETIS INC. |
| Draxxin | US6936592 | 29 May, 2018 | ZOETIS INC. |
Tulathromycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List